Twist Bioscience Corp — Director's Dealing 2018

Nov 1, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2018-10-30

Reporting Person: JOHANNESSEN JAN (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-10-30	Director Stock Option (right to buy)	$14.00	A	42304	Acquired	2028-10-29	Common Stock (42304)	Direct

Footnotes

F1: 1/3rd of the shares subject to the option vest and become exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vest and become exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.